Ibsa Institut Biochimique Savia Al Ponte 13 Ch 6903lugano Ticino 6903 Pma Numberp110005 Supplement Numbers011 Date Received02 16 2022 Decision Date03 18 2022 Product Code Moz Advisory Committee Orthopedic Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Ibsa Institut Biochimique Savia Al Ponte 13 Ch 6903lugano Ticino 6903 Pma Numberp110005 Supplement Numbers011 Date Received02 16 2022 Decision Date03 18 2022 Product Code Moz Advisory Committee Orthopedic Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P110005S011 IBSA INSTITUT BIOCHIMIQUE SAvia Al Ponte 13, Ch-6903lugano Ticino 6903 PMA NumberP110005 Supplement NumberS011 Date Received02/16/2022 Decision Date03/18/2022 Product Code MOZ  Advisory Committee Orthopedic Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No	GELSYN-3	2022-03-18